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Functional comparison between the human 
inferior epigastric artery and internal 
mammary artery 
Similarities and differences 
Although the inferior epigastric artery has been used as an alternative arterial graft for coronary artery 
bypass grafting, little is known about the contractile and relaxation characteristics of this artery. This 
study was designed to compare the pharmacologic reactivity of the two arterial conduits---the inferior 
epigastric artery and the internal mammary artery. Forty-one inferior epigastric artery ring segments 
from eight patients undergoing coronary grafting and 62 internal mammary artery ring segments were 
set up in organ baths under physiologic pressure. The contractility was determined from the contraction 
induced by the depolarizing agent potassium and receptor-mediated vasoconstrictor agents, norepineph- 
rine, U46619, and endothelin-1. Endothelium-dependent relaxation was induced by the calcium iono- 
phore A23187, a non-receptor agonist for endothelium-derived relaxing factor, and acetylcholine, a 
receptor agonist for endothelium-derived r laxing factor. Glyceryl trinitrate was used to study endothe- 
lium-independent relaxation. The maximal response (either contraction or relaxation) and the effective 
concentration causing 50% of the maximal response for these two arteries were compared. There was no 
difference (p > 0.05) either in the maximal contraction force (5.30 - 0.87 versus 4.76 -4-- 0.89 gin for 
potassium, 5.13 _ 0.67 versus 4.47 -+ 1.15 gm for norepinephrine, 8.04 +- 1.23 versus 6.23 -+ 0.99 gm for 
U46619, and 4.88 - 0.69 versus 5.57 - 0.93 for endothelin-1 (n = 6 to 10 for each vasoconstrictor) or in 
the maximal relaxation induced by giyceryl trinitrate (86.46% versus 92.98%, n -- 6) or by acetylcholine 
(20.72% versus 45.51%, n = 5) between the inferior epigastric artery and internal mammary artery. The 
effective concentration causing half maximal response to all vasoconstrictors and vasodilators was 
similar between the two arteries (p > 0.05). However, A23187 induced significantly less relaxation in the 
inferior epigastric artery (38.42 -+ 15.49%, n = 6) than in the internal mammary artery (71.89 -+ 7.17%, 
n = 9, p < 0.05). We conclude that contractility, endothelium-independent r laxation, and receptor- 
mediated endothelium-dependent relaxation are similar in the inferior epigastric artery and the internal 
mammary artery. However, the endothelium of this arterial graft has less ability to respond to the 
non-receptor-mediated en othelium-derived r laxing factor stimulant. The influence of this difference on 
the prevalence of atherosclerosis and long-term patency rate in the inferior epigastric artery remains to 
be studied. (J THORAC CARDIOVASC SURG 1995;109:13-20) 
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Although the internal mammary artery ( IMA) has 
been used for coronary artery bypass grafting 
(CABG) 1"6 and has yielded a superior long-term 
patency rate, the inferior epigastric artery ( IEA) has 
only recently been selected for use as a CABG 
conduit. 7-12 Preliminary clinical studies have sug- 
gested promising results for this graft, 7-12 although 
long-term patency rates are still unknown. In gen- 
eral, knowledge of the biologic characteristics of an 
arterial conduit is essential to understand its char- 
acteristics as a bypass graft. The present study was 
primarily designed to investigate the contractility, 
relaxation, and endothelial function of the IEA. The 
IMA, a well-studied arterial conduit for CABG, is 
used as a comparison. 
Material and methods 
Human IEA and IMA segments were collected from 
patients undergoing IEA and/or IMA graft operations. 
Approval to use discarded IEA and IMA tissue was given 
by the Human Ethics Committee of the Medical City 
Dallas Hospital. After sternotomy, a full-length left IMA 
pedicle was carefully dissected from the chest wall. Either 
the left or the right IEA was mobilized by a method 
described by Mills and Everson) 2The patients were then 
heparinized and cardiopulmonary bypass was instituted. 
The left IMA was cut distally and the length for grafting to 
the left anterior descending artery was carefully measured 
and preserved. The required length for the IEA was also 
carefully measured. Any discarded IEA or distal IMA 
segments were collected and put into a container with 
oxygenated physiologic (Krebs) solution maintained at 
4 ° C and then transferred to the laboratory immediately. 
The IEA and IMA were transferred into a glass dish and 
dissected out from their surrounding connective tissue. 
The arteries were then cut into 3 mm rings, and the rings 
1.~, 15 were suspended on wires in organ baths. - The number 
of rings taken from each patient varied from two to six. 
The rings used for the pharmacologic study were taken 
only from the section that did not show any gross athero- 
sclerosis. The Krebs solution had the following composi- 
tion (in millimoles per liter): Na + 144, K + 5.9, Ca z+ 2.5, 
Mg 2+ 1.2, C1- 128.7, HCO3- 25, 8042- 1.2, HePO4- 1.2, 
and glucose 11. The solution was aerated with a gas 
mixture of 95% oxygen and 5% carbon dioxide at 37 ° _+ 
0.1° C. 
Organ bath technique. An organ bath technique that 
allowed vascular ings to be normalized to a physiologic 
condition in vitro was used to set the vascular ings at a 
pressure comparable with that at the in vivo situation. The 
details of the technique were published before. 15' 16 In 
brief, both the lEA and IMA rings were stretched in 
progressive steps to determine the length-tension curve 
for each ring. A computer iterative fitting technique was 
used to determine the exponential line, pressure, and 
internal diameter. When the transmural pressure on the 
rings reached 100 mm Hg, determined from their own 
length-tension curves, the stretching procedure was 
stopped and the rings were then released to 90% of their 
internal circumference at 100 mm Hg. This degree of 
passive tension was then maintained throughout the ex- 
periment. 
We intentionally preserved the endothelium by cau- 
tiously dissecting and mounting the rings. We previously 
found that this technique allowed the experiments o be 
carried out with an intact endothelium, as determined by 
the functional relaxation response to acetylcholine. 14' 16 
Protocol. After the normalization procedure, the IEA 
and IMA rings were equilibrated for 45 minutes. The 
following protocols were designed for the experiments. 
Contraction. Diameters of the IEA and IMA at a 
pressure of 100 mm Hg were recorded from the normal- 
ization procedure. The cumulative concentration-contrac- 
tion curve was established for the following vasocon- 
strictor substances: endothelin-1; norepinephrine, a full 
adrenoceptor agonist; U46619, a stable thromboxane A 2 
mimetic; and a membrane depolarizing agent, potassium 
chloride. 
Relaxation. In this study, both endothelium-dependent 
and endothelium-independent r laxation were compared 
in the lEA and IMA. Relaxation was expressed as per- 
centage relaxation of the precontraction induced by 
U46619 (10 nmol/L). 
ENDOTHELIUM-DEPENDENT RELAXATION. 
1. Receptor-mediated ndothelium-dependent relax- 
ation was induced by acetylcholine, a receptor-mediated 
endothelium-derived r laxing factor-nitric oxide agonist. 
2. Non-receptor-mediated endothelium-dependent r - 
laxation was induced by calcium ionophore A23187 (cal- 
cimycin), a non-receptor-mediated en othelium-derived 
relaxing factor-nitric oxide agonist. 
ENOOTHELIUM-INDEVEYDEYr V, ELAXATION. Endothelium- 
independent relaxation was induced by glyceryl trinitrate. 
The reactivity of lEA and IMA was expressed as 
maximal contraction (or relaxation) and sensitivity. The 
sensitivity of the IEA and IMA to vasoconstrictor (endo- 
thelin-1, norepinephrine, U46619, and potassium) or va- 
sodilator (acetylcholine, A23187, or glyceryl trinitrate) 
agents is expressed by the effective concentration that 
induced 50% of the maximal effect (either contraction or 
relaxation; ECso). The ECso was determined from each 
concentration-contraction (or relaxation) curve by a logis- 
tic, curve-fitting equation: E = MAP/(A p + KP), where E 
is response, M is maximal contraction (or relaxation), A is 
concentration, K is ECso concentration, and p is the slope 
parameter.17 
The unpaired Student's t test was used to compare the 
contraction force or percentage r laxation for each vaso- 
constrictor, vasodilator, and the ECsos between the IEA 
and IMA. A p value less than 0:05 was considered 
significant. 
Drugs. Drugs used in this study and their resources 
were as follows: acetylcholine, A23187, and norepineph- 
rine bitartrate (Sigma Chemical Co., St. Louis, Mo.); 
U46619 (Cayman Chemical, Ann Arbor, Mich.); endothe- 
lin-1 (Peptides International, Louisville, Ky.); and glyceryl 
trinitrate (Roussel Canada Inc., Montreal, Quebec, Can- 
ada). Stock solution of norepinephrine and acetylcholine 
was freshly made each day. Stock solution of endothelin-1 
and U46619 was held frozen until required. 
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Table I. Comparison of the contractility of the lEA and the IMA to various vasoconstrictors 
Maximal contraction (gm) ECso (-log M) 
K U46619 ATE ET K (mmol/L) U46619 NE ET 
IEA 5.30 -+ 0.87 8.04 +- 1.23 5.13 +- 0.67 4.88 -+ 0.69 14.29 -+ 1.9 8.25 + 0.09 6.59 -+ 0.18 8.22 -+ 0.04 
(n=6)  (n=6)  (n=6)  (n=6)  
IMA 4.76 + 0.90 6.23 _+ 0.99 4.47 _+ 1.15 5.57 _+ 0.93 18.36 _+ 1.80 8.35 -+ 0.09 6.48 _+ 0.24 8.36 -+ 0.11 
(n = 14) (n = 13) (n = 6) (n = 6) 
p Value 0.72 0.30 0.63 0.56 0.20 0.51 0.71 0.27 
K, Potassium chloride; NE, norepinephrine; ET, endothelin-1; n, number of ring segments. 
Results 
Forty-one IEA rings and 62 IMA rings were 
studied. The diameter at a pressure of 100 mm Hg 
was 2.02 _+ 0.08 mm for the IEA and 2.22 -+ 0.07 mm 
for the IMA (p = 0.08). 
Contraction. Table I gives the details of the 
maximal contraction force and ECs0 value induced 
by endothelin-1, norepinephrine, potassium chlo- 
ride, and U46619 in IEA compared with IMA. No 
difference was noted between the IEA and IMA for 
all these four vasoconstrictors either in the maximal 
contraction or ECs0. The average concentration- 
contraction curves for these vasoconstrictors are 
shown in Fig. 1. 
Relaxation 
Endothelium-dependent relaxation. The maximal 
relaxation induced by acetylcholine was 20.72% _+ 
8.27% in IEA and 45.51% _+ 11.29% in IMA (p = 
0.15). A23187 induced significantly ess relaxation i  
IEA (38.42% _+ 15.49%) than in IMA (71.89% _+ 
7.17%, p < 0.05). No difference in the EC5o for 
either acetylcholine (-6.96 _+ 0.63 versus -6.69 _+ 
0.38 log M, p = 0.71) or A23187 (-6.38 _+ 0.47 
versus -6.88 _+ 0.36 log M,p = 0.42) was noted in 
the IEA and IMA. Fig. 2 a and b shows the average 
concentration-relaxation curves for acetylcholine 
and A23187 in lEA and IMA. 
Endothelium-independent relaxation. No differ- 
ence was noted between IEA and IMA in either the 
maximal relaxation induced by glyceryl trinitrate 
(86.46% _+ 3.54% and 92.98% + 2.45%, p = 0.14) 
or the ECs0 (-7.22 + 1.53 versus -7.53 _+ 0.16 log 
M, p = 0.81) to glyceryl trinitrate. Fig. 3 shows the 
average concentration-relaxation curve for glyceryl 
trinitrate in IEA and IMA. 
Discussion 
IMA has been successfully applied in CABG 
because of its high long-term patency rate over 
saphenous vein grafts and its safety) "6 This graft has 
become the most common arterial graft, and IMA 
grafting is a routine procedure for most cardiac 
surgeons. Biologic characteristics of this graft such 
as pharmacologic reactivity have been extensively 
studied.13-16, a8,19 In contrast, IEA is a newly sug- 
gested arterial conduit for CABG 7 and its long-term 
patency rate is not yet known. Also, little is known 
regarding its pharmacologic reactivity and endothe- 
lial function. Therefore, we designed this study to 
investigate he pharmacologic reactivity of this graft 
conduit in regard to the smooth muscle as well as 
endothelial function. IMA, the well-studied arterial 
graft conduit, is used as a comparison. 
The major findings from this study are as follows: 
(1) the contractility, receptor-mediated endotheli- 
urn-dependent relaxation and endothelium-inde- 
pendent relaxation of IEA are similar to those of 
IMA; (2) the non-receptor-mediated en othelium- 
dependent relaxation (to the calcium ionophore 
A23187) is less potent in IEA than in IMA. 
In the present study, four vasoconstrictors (endo- 
thelin-1, norepinephrine, U46619, and potassium 
chloride) were used to test the contractility of IEA. 
Endothelin-1 has been proposed as the most potent 
vasoconstrictor known. 2° Elevated plasma level has 
been measured uring cardiopulmonary b pass. 21 
Therefore, this vasoconstrictor may have a patho- 
genic significance in vasospasm related to cardiac 
surgery. Norepinephrine was selected for the 
present study because it is a full adrenoceptor 
agonist; its effect on human IMA has been exten- 
sively studied. 13' 15, 16, 22, 23 The thromboxane A 2 mi- 
metic, U46619, was used in this study because this 
vasoconstrictor is a potent agonist in IMA and, like 
endothelin-1, elevated plasma level of thromboxane 
A2 has been found. 24' 25 In addition, the cellular 
membrane depolarizing agent, potassium ion (K+), 
was also used to study contractility. In all these 
studies regarding the contractile property of the 
smooth muscle of the lEA, the artery contracted 
well, which suggests hat IEA is a pharmacologically 
reactive blood vessel. The similar contraction be- 
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Fig. 1. Mean concentration (-log M)-contraction (force, g) curves for endothelin-1 (endothelin, a), 
norepinephrine (b), potassium (K, c), and U46619 (d) in the IEA and IMA. Symbols represent data 
averaged from at least six IEA or IMA rings (see Table I forthe number of the rings). Horizontal bars are 
placed on ECso values (_+ 1 standard error of the mean), averaged from logistic, fitted curves from each 
ring. Vertical bars are 1 standard error of the mean at the maximum response. 
tween this artery and IMA is demonstrated in two 
ways. First, the maximal contraction force between 
these two arteries is similar for all of the four 
vasoconstrictors tested (see Fig. 1). Second, the 
sensitivity of the two arteries to the various vasocon- 
strictors is also similar, indicated by the similar ECs0 
to all the four vasoconstrictors tested. 
The comparison in regard to the relaxation stud- 
ies is more complicated than the contraction studies. 
Vascular relaxation may be classified as endothe- 
lium dependent and endothelium independent. In
regard to endothelium-independent r laxation, glyc- 
eryl trinitrate induced similar relaxation in IEA and 
IMA. This again suggests that the function of the 
smooth muscle cells of these two arteries is similar. 
However, endothelium-dependent relaxation was 
different in IEA and IMA. The endothelium-depen- 
dent relaxation may be evoked by agonists acting on 
receptors located on the endothelial membrane 
through endothelium-derived r laxing factor-nitric 
oxide pathway or other pathways uch as endothe- 
lium-derived hyperpolarizing factor formation. In 
the present study, we used acetylcholine, a classic 
receptor-mediated endothelium-derived relaxing 
factor agonist, to study endothelium-dependent r - 
laxation. This agonist induced a slightly less, but not 
statistically significant, relaxation in the IEA than in 
the IMA. Endothelium-dependent relaxation can 
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Fig. 2. Mean concentration ( - log  M)-relaxation (percent of precontraction) curves for acetylcholine 
(ACh, a; n = 5 in each group) or calcium ionophore A23187 (b; n = 6 in each group). Symbols represent 
data averaged from IEA and IMA rings. The precontraction was induced by U46619 (10 nmol/L). Vertical 
bars are 1 standard error of the mean of the response at each concentration. 
also be evoked by nonreceptor stimulants uch as 
calcium ionophore A23187. Calcium ionophore in- 
creases intracellular calcium level of the endothelial 
cells through a non-receptor mechanism. The in- 
creased intracellular calcium, as the second messen- 
ger, modulates the endothelium-derived r laxing 
factor (nitric oxide) formation, which subsequently 
relaxes smooth muscle through a cyclic guanosine 
monophosphate mechanism. In the present study, 
A23187 induced significantly ess relaxation in IEA 
than in IMA, this is the only significant difference 
found between these two arteries in terms of phar- 
macologic reactivity from our study. This finding 
obviously suggests that the endothelial cells of the 
IEA have less capacity to release endothelium- 
derived relaxing factor (nitric oxide) than those of 
the IMA in response to the stimulation of the 
calcium ionophore. Because endothelium-derived 
relaxing factor (nitric oxide) release has been 
thought to be important o maintain long-term 
patency, is the influence of this difference on the 
long-term patency rate of the IEA remains to be 
studied. 
One of the advantages to use of the IMA as a 
graft is that this artery is usually thought to be free 
from atherosclerosis. 26 This well-known characteris- 
tic of the IMA may partially account for its high 
long-term patency rate. However, the prevalence of 
atherosclerosis of the IEA is still unknown. In our 
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Fig. 3. Mean concentration ( - log  M)-relaxation (per- 
cent of precontraction) curves for glyceryl trinitrate 
(GTN). Symbols represent data averaged from six IEA 
and IMA rings. The precontraction was induced by 
U46619 (10 nmol/L). Vertical bars are 1 standard error of 
the mean of the response at each concentration. 
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Fig. 4. Photomicrographs of IEA and IMA from one patient. A, Cross section of the IEA with an average 
diameter of 2.2 mm demonstrates a prominent eccentric intimal arteriosclerotic plaque with marked 
thinning of subjacent media. The lumen is narrowed to less than 20% to 25% of the expected 
cross-sectional area. In contrast, he cross section of the left IMA (B) and right IMA (C) demonstrates a 
normal muscular media with no intimal arteriosclerosis. 
practice, we have found that two of the first eight 
patients undergoing IEA grafting had grossly de- 
tected atherosclerosis on the proximal section of the 
artery. Pathologic study from one of these patients 
showed that the IEA had a prominent eccentric 
intimal arteriosclerotic plaque with marked thinning 
of subjacent media, and the lumen was narrowed to 
less than 20% to 25% of the expected cross-sec- 
tional area. Interestingly, although this significant 
atherosclerotic lesion was seen in the IEA, the 
IMAs (either the left or the right IMA) of this 
patient remained free from atherosclerosis a dem- 
onstrated in Fig. 4. The fact that in two of eight 
patients the IEA shows gross atherosclerosis and 
that the patient whose IEA was atherosclerotic had 
normal bilateral IMA remained free from athero- 
sclerosis may suggest hat atherosclerosis is more 
prevalent in the IEA than in the IMA. The less 
potent non-receptor-mediated en othelium-depen- 
dent relaxation in the IEA, as found in the present 
study, may imply an early lesion of atherosclerosis. 
Although the IEA rings used in the present study 
were free from gross atherosclerosis, some of these 
segments may have an early atherosclerotic lesion. 
Others have demonstrated that in atherosclerotic 
human arteries, stimulated and basal release of 
endothelium-dependent relaxing factor is im- 
paired27, 28 and the attenuation of the endothelium- 
mediated vasodilatation is selective. 29 This is in 
accordance with our observation in the present 
study. Our finding of impaired nonreceptor-medi- 
ated endothelium-dependent r laxation in the IEA 
may suggest that decreased endothelium-dependent 
relaxation may be an early sign of atherosclerosis in 
the IEA. 
In conclusion, we have found from the present 
study that the pharmacologic reactivity and the size 
of the human IEA are similar to those of the IMA. 
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The only difference between these two arterial con- 
duits in regard to pharmacologic reactivity, found in 
the present study, is that the IEA has a reduced 
nonreceptor-mediated endothelium-dependent re- 
laxation. It may be suspected that this reduced 
relaxation is possibly correlated to early atheroscle- 
rosis. The influence of this difference on the long- 
term patency remains to be studied. 
We are grateful to Dr. Wayne E. Taylor for his assis- 
tance in pathologic study. We are also grateful to Chris- 
tine Coleman, RN, and Carol Nicholson, RN, MS, for 
their valuable technical assistance. 
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